Collaborative partnerships can foster success in formulation development projects.

Developing the Best Formulation Partnership

The CRO market will see consolidation by financial buyers and larger CRO players.

Pharma Services Sector Poised for Continued Growth

Topic

Articles

AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.

AGC Bio Boosts Manufacturing Capacity for pDNA and mRNA at Heidelberg Facility

Sterling Pharma Solutions has invested in a center of excellence for research into commercial applications of continuous flow chemistry at its site in Dudley, UK.

Sterling Pharma Solutions Set to Create Center of Excellence in Continuous Flow Chemistry in UK

Garrett Perry is a technical services specialist at Teknova, www.teknova.com.

As interest in cell and gene therapies continues to grow, the need for safe and consistent reagents to support research, development, and manufacture efforts also increases. 

How Pure is Pure? Understanding Reagent Purity Grades

Zillery A. Fortner is product marketing manager, Sparta Systems, A Honeywell Company.

The functionality of a digital quality management system (QMS) provides visibility into critical supplier activity and helps ensure a high-quality product. 

Mitigating Third-Party Risks: The Benefits of Extending Quality to the Supply Chain   

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Vincent Colicchio, vice president, supply chain and external manufacturing at Dr. Reddy’s Laboratories, discusses how a lack of proper supplier oversight can impact the pharmaceutical industry and the drug supply chain.

The Impact of Insufficient Oversight

Febles will oversee day-to-day aseptic manufacturing at Pharmaceutics International, Inc.

Pii Hires Roberto Almodóvar Febles as Head of Aseptic Operations

Quotient Sciences is investing £6.3 million ($8.68 million) into their drug substance manufacturing capabilities.

Quotient Sciences Makes Multi-Million Dollar Investment to Expand Drug Substance Manufacturing Facility

AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.

AGC Biologics Breaks Ground on New Multipurpose Facility in Denmark

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Lonza Invests in Drug Product Manufacturing Services in China

Curia plans to expand the site’s commercial capabilities with this move.

Outsourcing

Developing the Best Formulation Partnership

Pharma Services Sector Poised for Continued Growth